In vitro activity of ceftaroline against gram-positive and gram-negative pathogens isolated from patients in Canadian hospitals in 2009.
about
Alternative strategies for proof-of-principle studies of antibacterial agentsCoagulase-negative staphylococci.Description and validation of a spectrum score method to measure antimicrobial de-escalation in healthcare associated pneumonia from electronic medical records data.Investigational antimicrobial agents of 2013.Reduced In Vitro Activity of Ceftaroline by Etest among Clonal Complex 239 Methicillin-Resistant Staphylococcus aureus Clinical Strains from AustraliaSingle- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjectsIn vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance studyWill new antimicrobials overcome resistance among Gram-negatives?Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections.Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection.Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA.Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.New antibiotics for bad bugs: where are we?β-lactam/β-lactamase inhibitor combinations: from then to now.β-Lactams and β-Lactamase Inhibitors: An Overview.Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers.Differences in the pharmacodynamics of ceftaroline against different species of Enterobacteriaceae studied in an in vitro pharmacokinetic model of infection.Pharmacodynamics of ceftaroline against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.Analysis of Potential β-Lactam Surrogates to Predict In Vitro Susceptibility and Resistance to Ceftaroline for Clinical Isolates of Enterobacteriaceae.
P2860
Q26850895-99674284-59EB-4EB3-AF7B-49B451C096F9Q30401758-0DAC0EB2-2295-49C4-8439-270B3566B6A2Q30647100-BBE89317-1C8D-4F1E-8877-3E7048BC7410Q34375204-937B4A40-2006-44C1-8D8B-26283CB70B83Q36290502-EA34D137-72B1-4D20-BD4E-8E4447F0A9F9Q36667104-0F07C211-CCA4-4503-A74C-9A31A359B848Q37263425-E8DA6A63-B017-45DF-837A-BC0C41AB9CD0Q37942654-0BA2098F-D70C-4D49-B595-D6CD102A1996Q38006689-EF0C4833-924F-460A-9CD3-86AC01E65503Q38010783-34E78229-AEB3-4DB3-8301-1600652E2781Q38025132-7225A01F-F93A-4CC8-A6A6-D29DE54E1FE5Q38035808-6B2191AD-0910-4FA1-8C08-8E13A1133983Q38061168-E3C72872-C80B-450E-8AEB-2B395DDAAA53Q38117077-7004C3E0-8110-46FA-A5B1-35067780A1DBQ38132217-E9CEC5DA-4D41-41B0-AD50-2B1FD1F4C656Q38264182-A8AD723E-180F-4120-A910-A5B1A8641B86Q38872374-AFE02F3F-14ED-4E88-B3E9-54C6B3B773B1Q39682573-D966C3B6-8E70-4A4F-B426-CA1761288DBEQ40804939-4505D4D5-EC2C-4805-944E-9679AB01CF33Q42275442-FC6D8A77-A8FE-4A85-ADEE-15C4B4030746Q50048535-3C5571C8-564F-411F-A09E-6BAC5B1358AA
P2860
In vitro activity of ceftaroline against gram-positive and gram-negative pathogens isolated from patients in Canadian hospitals in 2009.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
In vitro activity of ceftaroli ...... in Canadian hospitals in 2009.
@ast
In vitro activity of ceftaroli ...... in Canadian hospitals in 2009.
@en
type
label
In vitro activity of ceftaroli ...... in Canadian hospitals in 2009.
@ast
In vitro activity of ceftaroli ...... in Canadian hospitals in 2009.
@en
prefLabel
In vitro activity of ceftaroli ...... in Canadian hospitals in 2009.
@ast
In vitro activity of ceftaroli ...... in Canadian hospitals in 2009.
@en
P2093
P2860
P356
P1476
In vitro activity of ceftaroli ...... in Canadian hospitals in 2009
@en
P2093
Daryl J Hoban
Heather J Adam
James A Karlowsky
Melanie R Decorby
P2860
P304
P356
10.1128/AAC.01787-10
P407
P577
2011-03-14T00:00:00Z